Form 8-K - Current report:
SEC Accession No. 0001628280-24-035388
Filing Date
2024-08-07
Accepted
2024-08-07 08:01:33
Documents
15
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K petq-20240807.htm   iXBRL 8-K 28331
2 EX-99.1 petq-20240807xex991earning.htm EX-99.1 310647
6 logo.jpg GRAPHIC 18463
  Complete submission text file 0001628280-24-035388.txt   513107

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT petq-20240807.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT petq-20240807_lab.xml EX-101.LAB 21625
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT petq-20240807_pre.xml EX-101.PRE 12504
17 EXTRACTED XBRL INSTANCE DOCUMENT petq-20240807_htm.xml XML 3552
Mailing Address PETIQ LLC 230 E. RIVERSIDE DR. EAGLE ID 83616
Business Address PETIQ LLC 230 E. RIVERSIDE DR. EAGLE ID 83616 208-939-8900
PetIQ, Inc. (Filer) CIK: 0001668673 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38163 | Film No.: 241181509
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)